论文部分内容阅读
目的探讨氯吡格雷改善急性脑梗死患者神经功能的临床疗效。方法选取急性脑梗死患者88例,将其采用随机数字表法分为两组,其中观察组45例患者给予氯吡格雷治疗,对照组43例患者给予血栓通治疗,观察并比较两组患者神经功能缺损评分与高敏C-反应蛋白(hs-CRP)及临床疗效。结果治疗14 d后,观察组患者优良率、hs-CRP与神经功能缺损评分均明显优于对照组,差异均有统计学意义(均P<0.05)。结论氯吡格雷治疗急性脑梗死患者能有效改善其神经功能。
Objective To investigate the clinical efficacy of clopidogrel in improving neurological function in patients with acute cerebral infarction. Methods A total of 88 patients with acute cerebral infarction were selected and divided into two groups according to the random number table. Among them, 45 patients in the observation group were treated with clopidogrel, 43 in the control group were treated with Xueshuantong, and the nerve in the two groups was observed and compared Functional impairment score and high-sensitivity C-reactive protein (hs-CRP) and clinical efficacy. Results After 14 days of treatment, the excellent and good rates of hs-CRP and neurological deficit in the observation group were significantly better than those in the control group (all P <0.05). Conclusion Clopidogrel treatment of acute cerebral infarction patients can effectively improve their neurological function.